These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 22795898)

  • 1. Synthesis and biological activity of novel bifunctional isoxazolidinyl polycyclic aromatic hydrocarbons.
    Rescifina A; Zagni C; Romeo G; Sortino S
    Bioorg Med Chem; 2012 Aug; 20(16):4978-84. PubMed ID: 22795898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological activity of isoxazolidinyl polycyclic aromatic hydrocarbons: potential DNA intercalators.
    Rescifina A; Chiacchio MA; Corsaro A; De Clercq E; Iannazzo D; Mastino A; Piperno A; Romeo G; Romeo R; Valveri V
    J Med Chem; 2006 Jan; 49(2):709-15. PubMed ID: 16420056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoxazolidinyl polycyclic aromatic hydrocarbons as DNA-intercalating antitumor agents.
    Rescifina A; Chiacchio U; Corsaro A; Piperno A; Romeo R
    Eur J Med Chem; 2011 Jan; 46(1):129-36. PubMed ID: 21093966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel isoxazole polycyclic aromatic hydrocarbons as DNA-intercalating agents.
    Rescifina A; Varrica MG; Carnovale C; Romeo G; Chiacchio U
    Eur J Med Chem; 2012 May; 51():163-73. PubMed ID: 22405647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological activity of new arenediyne-linked isoxazolidines.
    Romeo R; Navarra M; Giofrè SV; Carnovale C; Cirmi S; Lanza G; Chiacchio MA
    Bioorg Med Chem; 2014 Jul; 22(13):3379-85. PubMed ID: 24835789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, electrophilic substitution and structure-activity relationship studies of polycyclic aromatic compounds towards the development of anticancer agents.
    Banik BK; Becker FF
    Curr Med Chem; 2001 Oct; 8(12):1513-33. PubMed ID: 11562280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and cytotoxic activity evaluation of some novel 1-(3-(aryl-4,5-dihydroisoxazol-5-yl)methyl)-4-trihalomethyl-1H-pyrimidin-2-ones in human cancer cells.
    Lobo MM; Viau CM; Dos Santos JM; Bonacorso HG; Martins MA; Amaral SS; Saffi J; Zanatta N
    Eur J Med Chem; 2015 Aug; 101():836-42. PubMed ID: 26275603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA intercalators based on (1,10-phenanthrolin-2-yl)isoxazolidin-5-yl core with better growth inhibition and selectivity than cisplatin upon head and neck squamous cells carcinoma.
    Varrica MG; Zagni C; Mineo PG; Floresta G; Monciino G; Pistarà V; Abbadessa A; Nicosia A; Castilho RM; Amata E; Rescifina A
    Eur J Med Chem; 2018 Jan; 143():583-590. PubMed ID: 29207341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of 3,5-diaryl isoxazoline/isoxazole linked 2,3-dihydroquinazolinone hybrids as anticancer agents.
    Kamal A; Bharathi EV; Reddy JS; Ramaiah MJ; Dastagiri D; Reddy MK; Viswanath A; Reddy TL; Shaik TB; Pushpavalli SN; Bhadra MP
    Eur J Med Chem; 2011 Feb; 46(2):691-703. PubMed ID: 21194809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and anticancer activity of novel spiro-isoxazoline and spiro-isoxazolidine derivatives of α-santonin.
    Khazir J; Singh PP; Reddy DM; Hyder I; Shafi S; Sawant SD; Chashoo G; Mahajan A; Alam MS; Saxena AK; Arvinda S; Gupta BD; Kumar HM
    Eur J Med Chem; 2013 May; 63():279-89. PubMed ID: 23501113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiproliferative novel isoxazoles: modeling, virtual screening, synthesis, and bioactivity evaluation.
    Tzanetou E; Liekens S; Kasiotis KM; Melagraki G; Afantitis A; Fokialakis N; Haroutounian SA
    Eur J Med Chem; 2014 Jun; 81():139-49. PubMed ID: 24836066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological properties of 5-(1H-1,2,3-triazol-4-yl)isoxazolidines: a new class of C-nucleosides.
    Giofrè SV; Romeo R; Carnovale C; Mancuso R; Cirmi S; Navarra M; Garozzo A; Chiacchio MA
    Molecules; 2015 Mar; 20(4):5260-75. PubMed ID: 25812148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and structure-activity relationships of pyridinyl-1H-1,2,3-triazolyldihydroisoxazoles as potent inhibitors of tubulin polymerization.
    Suman P; Murthy TR; Rajkumar K; Srikanth D; Dayakar Ch; Kishor C; Addlagatta A; Kalivendi SV; Raju BC
    Eur J Med Chem; 2015 Jan; 90():603-19. PubMed ID: 25499929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of 3-hydroxymethyl-5-(1H-1,2,3-triazol) isoxazolidines.
    Romeo R; Giofrè SV; Carnovale C; Campisi A; Parenti R; Bandini L; Chiacchio MA
    Bioorg Med Chem; 2013 Dec; 21(24):7929-37. PubMed ID: 24436994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, characterization and biological evaluation of some novel 17-isoxazoles in the estrone series.
    Kovács D; Kádár Z; Mótyán G; Schneider G; Wölfling J; Zupkó I; Frank E
    Steroids; 2012 Sep; 77(11):1075-85. PubMed ID: 22613036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regioselective synthesis of 3,4-diaryl-5-unsubstituted isoxazoles, analogues of natural cytostatic combretastatin A4.
    Chernysheva NB; Maksimenko AS; Andreyanov FA; Kislyi VP; Strelenko YA; Khrustalev VN; Semenova MN; Semenov VV
    Eur J Med Chem; 2018 Feb; 146():511-518. PubMed ID: 29407976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of 4-arylamido 3-methyl isoxazole derivatives as novel FMS kinase inhibitors.
    Im D; Jung K; Yang S; Aman W; Hah JM
    Eur J Med Chem; 2015 Sep; 102():600-10. PubMed ID: 26318067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of Spiro[indole-3,5'-isoxazoles] with Anticancer Activity via a Formal [4 + 1]-Spirocyclization of Nitroalkenes to Indoles.
    Aksenov AV; Aksenov DA; Arutiunov NA; Aksenov NA; Aleksandrova EV; Zhao Z; Du L; Kornienko A; Rubin M
    J Org Chem; 2019 Jun; 84(11):7123-7137. PubMed ID: 31070030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and cytotoxicity of a new series of isoxazolidine based nucleoside analogues.
    Piotrowska DG; Cieślak M; Królewska K; Wróblewski AE
    Arch Pharm (Weinheim); 2011 May; 344(5):301-10. PubMed ID: 21312233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, antiviral, and cytostatic evaluation of novel isoxazolidine analogs of homonucleotides.
    Łysakowska M; Balzarini J; Piotrowska DG
    Arch Pharm (Weinheim); 2014 May; 347(5):341-53. PubMed ID: 24535944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.